Genzyme (GENZ) Completes $265M Diagnostic Business Sale; To Sell Pharma Intermediates Business
Tweet Send to a Friend
Genzyme Corporation (Nasdaq: GENZ) announced that they have completed the $265 million cash sale ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
